Prevention of congenital rubella in Iceland by antibody screening and immunization of seronegative females

A programme to eradicate congenital rubella from Iceland was started in 1979, based on (1) screening of all females aged 12-45 years for rubella antibodies and (2) vaccination of all seronegative persons with the RA/27/3 rubella vaccine, given free of charge. Thus, individual protection was offered...

Full description

Bibliographic Details
Main Authors: Gudmundsdóttir, S., Antonsdóttir, A., Gudnadóttir, S., Elefsen, S., Einarsdóttir, B., Ólafsson, Ó., Gudnadóttir, M.
Format: Text
Language:English
Published: 1985
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536347
http://www.ncbi.nlm.nih.gov/pubmed/3872738
id ftpubmed:oai:pubmedcentral.nih.gov:2536347
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:2536347 2023-05-15T16:46:11+02:00 Prevention of congenital rubella in Iceland by antibody screening and immunization of seronegative females Gudmundsdóttir, S. Antonsdóttir, A. Gudnadóttir, S. Elefsen, S. Einarsdóttir, B. Ólafsson, Ó. Gudnadóttir, M. 1985 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536347 http://www.ncbi.nlm.nih.gov/pubmed/3872738 en eng http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536347 http://www.ncbi.nlm.nih.gov/pubmed/3872738 Research Text 1985 ftpubmed 2013-09-02T05:23:49Z A programme to eradicate congenital rubella from Iceland was started in 1979, based on (1) screening of all females aged 12-45 years for rubella antibodies and (2) vaccination of all seronegative persons with the RA/27/3 rubella vaccine, given free of charge. Thus, individual protection was offered to all who needed it. The collection of serum samples was planned to last for 2 years while, simultaneously, the already established rubella screening and immunization programmes for 12-year-old schoolgirls and pregnant women continued. Text Iceland PubMed Central (PMC)
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Research
spellingShingle Research
Gudmundsdóttir, S.
Antonsdóttir, A.
Gudnadóttir, S.
Elefsen, S.
Einarsdóttir, B.
Ólafsson, Ó.
Gudnadóttir, M.
Prevention of congenital rubella in Iceland by antibody screening and immunization of seronegative females
topic_facet Research
description A programme to eradicate congenital rubella from Iceland was started in 1979, based on (1) screening of all females aged 12-45 years for rubella antibodies and (2) vaccination of all seronegative persons with the RA/27/3 rubella vaccine, given free of charge. Thus, individual protection was offered to all who needed it. The collection of serum samples was planned to last for 2 years while, simultaneously, the already established rubella screening and immunization programmes for 12-year-old schoolgirls and pregnant women continued.
format Text
author Gudmundsdóttir, S.
Antonsdóttir, A.
Gudnadóttir, S.
Elefsen, S.
Einarsdóttir, B.
Ólafsson, Ó.
Gudnadóttir, M.
author_facet Gudmundsdóttir, S.
Antonsdóttir, A.
Gudnadóttir, S.
Elefsen, S.
Einarsdóttir, B.
Ólafsson, Ó.
Gudnadóttir, M.
author_sort Gudmundsdóttir, S.
title Prevention of congenital rubella in Iceland by antibody screening and immunization of seronegative females
title_short Prevention of congenital rubella in Iceland by antibody screening and immunization of seronegative females
title_full Prevention of congenital rubella in Iceland by antibody screening and immunization of seronegative females
title_fullStr Prevention of congenital rubella in Iceland by antibody screening and immunization of seronegative females
title_full_unstemmed Prevention of congenital rubella in Iceland by antibody screening and immunization of seronegative females
title_sort prevention of congenital rubella in iceland by antibody screening and immunization of seronegative females
publishDate 1985
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536347
http://www.ncbi.nlm.nih.gov/pubmed/3872738
genre Iceland
genre_facet Iceland
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536347
http://www.ncbi.nlm.nih.gov/pubmed/3872738
_version_ 1766036304099803136